Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.

Cai H, Everett RS, Thakker DR.

Br J Pharmacol. 2019 Aug;176(15):2724-2735. doi: 10.1111/bph.14694. Epub 2019 Jun 26.

PMID:
31032880
2.

Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis.

Proctor WR, Ming X, Bourdet D, Han TK, Everett RS, Thakker DR.

J Pharm Sci. 2016 Feb;105(2):484-496. doi: 10.1016/j.xphs.2015.11.040. Review.

PMID:
26869413
3.

Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.

Cai H, Zhang Y, Han TK, Everett RS, Thakker DR.

Int J Cancer. 2016 May 1;138(9):2281-92. doi: 10.1002/ijc.29965. Epub 2016 Jan 8.

4.

Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.

Han TK, Proctor WR, Costales CL, Cai H, Everett RS, Thakker DR.

J Pharmacol Exp Ther. 2015 Mar;352(3):519-28. doi: 10.1124/jpet.114.220350. Epub 2015 Jan 6.

5.

Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes.

Han TK, Everett RS, Proctor WR, Ng CM, Costales CL, Brouwer KL, Thakker DR.

Mol Pharmacol. 2013 Aug;84(2):182-9. doi: 10.1124/mol.112.084517. Epub 2013 May 16.

6.

Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo.

Hartman ZC, Kiang A, Everett RS, Serra D, Yang XY, Clay TM, Amalfitano A.

J Virol. 2007 Feb;81(4):1796-812. Epub 2006 Nov 22.

7.

Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system.

Kiang A, Hartman ZC, Everett RS, Serra D, Jiang H, Frank MM, Amalfitano A.

Mol Ther. 2006 Oct;14(4):588-98. Epub 2006 Jun 2.

8.

Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide.

Everett RS, Vanhook MK, Barozzi N, Toth I, Johnson LG.

Mol Pharmacol. 2006 Feb;69(2):492-500. Epub 2005 Nov 15.

PMID:
16288084
9.

Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors.

Everett RS, Evans HK, Hodges BL, Ding EY, Serra DM, Amalfitano A.

Virology. 2004 Jul 20;325(1):96-105.

10.

Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.

Everett RS, Hodges BL, Ding EY, Xu F, Serra D, Amalfitano A.

Hum Gene Ther. 2003 Dec 10;14(18):1715-26.

PMID:
14670123
11.

Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications.

Hodges BL, Evans HK, Everett RS, Ding EY, Serra D, Amalfitano A.

J Virol. 2001 Jul;75(13):5913-20.

12.

Factors affecting production of luciferase and epitope-tagged IGF-I in porcine muscle after DNA injection.

Everett RS, Gerrard DE, Grant AL.

J Endocrinol. 2000 Aug;166(2):255-63.

PMID:
10927615
13.

Epitope-tagged insulin-like growth factor-I expression in muscle.

Reichel CL, Grant AL, Everett RS, Bidwell CA, Gerrard DE.

Domest Anim Endocrinol. 2000 Apr;18(3):337-48.

PMID:
10793272

Supplemental Content

Loading ...
Support Center